A prospective open label 2–8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headacheResearch in context

A prospective open label 2–8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headacheResearch in context

Summary: Background: We demonstrated in the randomised controlled ICON study that 48-week treatment of medically intractable chronic cluster headache (MICCH) with occipital nerve stimulation (ONS) is safe and effective. In L-ICON we prospectively evaluate its long-term effectiveness and safety. Met...

Full description

Bibliographic Details
Main Authors: Roemer B. Brandt, Leopoldine A. Wilbrink, Ilse F. de Coo, Joost Haan, Wim M. Mulleners, Frank J.P.M. Huygen, Erik W. van Zwet, Michel D. Ferrari, Rolf Fronczek, Ilse F. De Coo, Patty G. Doesborg, Eveline C. Bartels, Erik W. Van Zwet, Erkan Kurt, Robert T.M. Van Dongen, Onno P.M. Teernstra, Peter J. Koehler, Geert H. Spincemaille, Frank Wille, Katja Burger, Emile G.M. Couturier, Jan Willem Kallewaard, Peter H. Veltink, R. Buschman
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:EBioMedicine
Subjects:
Cluster headache
Medically intractable chronic cluster headache
Occipital nerve stimulation
Neuromodulation
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423004619

Internet

http://www.sciencedirect.com/science/article/pii/S2352396423004619

Similar Items